【화학정보학】 암종에 따른 약물 종류

암종에 따른 약물 종류(examples of drugs according to cancer types)

 

추천글 : 【화학정보학】 물질 라이브러리 

출처 : NCI 2020

---

a. 약물 라이브러리

b. 약물 클래스 라이브러리

---

 

drugs_according_to_cancer types.csv

0.01MB

 

1. Lymphoma (30)

○ Ibritumomab tiuxetan (ZevalinⓇ)

○ Denileukin diftitox (OntakⓇ)

○ Brentuximab vedotin (AdcetrisⓇ)

○ Rituximab (RituxanⓇ)

○ Vorinostat (ZolinzaⓇ)

○ Romidepsin (IstodaxⓇ)

○ Bexarotene (TargretinⓇ)

○ Bortezomib (VelcadeⓇ)

○ Pralatrexate (FolotynⓇ)

○ Ibrutinib (ImbruvicaⓇ)

○ Siltuximab (SylvantⓇ)

○ Idelalisib (ZydeligⓇ)

○ Belinostat (BeleodaqⓇ)

○ Obinutuzumab (GazyvaⓇ)

○ Nivolumab (OpdivoⓇ)

○ Pembrolizumab (KeytrudaⓇ)

○ Rituximab & Hyaluronidase human (Rituxan Hycela™)

○ Copanlisib hydrochloride (Aliqopa™)

○ Axicabtagene ciloleucel (Yescarta™)

○ Acalabrutinib (CalquenceⓇ)

○ Tisagenlecleucel (KymriahⓇ)

○ Venetoclax (Venclexta™)

○ Mogamulizumab-kpkc (PoteligeoⓇ)

○ Duvelisib (Copiktra™)

○ Polatuzumab vedotin-piiq (Polivy™)

○ Zanubrutinib (Brukinsa™)

○ Tazemetostat hydrobromide (Tazverik™)

○ Selinexor (Xpovio™)

○ Tafasitamab-cxix (MonjuviⓇ)

○ Brexucabtagene autoleucel (Tecartus™)

 

 

2. Leukemia (27)

○ Tretinoin (VesanoidⓇ)

○ Imatinib mesylate (GleevecⓇ)

○ Dasatinib (SprycelⓇ)

○ Nilotinib (TasignaⓇ)

○ Bosutinib (BosulifⓇ)

○ Rituximab (RituxanⓇ)

○ Alemtuzumab (CampathⓇ)

○ Ofatumumab (ArzerraⓇ)

○ Obinutuzumab (GazyvaⓇ)

○ Ibrutinib (ImbruvicaⓇ)

○ Idelalisib (ZydeligⓇ)

○ Blinatumomab (BlincytoⓇ)

○ Venetoclax (Vendexta™)

○ Ponatinib hydrochloride (IclusigⓇ)

○ Midostaurin (RydaptⓇ)

○ Enasidenib mesylate (IdhifaⓇ)

○ Inotuzumab ozogamicin (BesponsaⓇ)

○ Tisagenledeucel (KymriahⓇ)

○ Gemtuzumab ozogamicin (Mylotarg™)

○ Rituximab & Hyaluronidase human (Rituxan Hycela™)

○ Ivosidenib (TibsovoⓇ)

○ Duvelisib (Copiktra™)

○ Moxetumomab pasudotox-tdfk (Lumoxiti™)

○ Glasdegib maleate (Daurismo™)

○ Gilteritinib (XospataⓇ)

○ Tagraxofusp-erzs (Elzonris™)

○ Acalabrutinib (CalquenceⓇ)

 

 

3. Breast (25)

○ Everolimus (AfinitorⓇ)

○ Tamoxifen (Nolvadex)

○ Toremifene (FarestonⓇ)

○ Trastuzumab (HerceptinⓇ)

○ Fulvestrant (FaslodexⓇ)

○ Anastrozole (ArimidexⓇ)

○ Exemestane (AromasinⓇ)

○ Lapatinib (TykerbⓇ)

○ Letrozole (FemaraⓇ)

○ Pertuzumab (PerjetaⓇ)

○ Ado-trastuzumab emtansine (KadcylaⓇ)

○ Palbociclib (IbranceⓇ)

○ Ribociclib (KisqaliⓇ)

○ Neratinib maleate (Nerlynx™)

○ Abemaciclib (Verzenio™)

○ Olaparib (Lynparza™)

○ Talazoparib tosylate (TalzennaⓇ)

○ Atezolizumab (TecentriqⓇ)

○ Alpelisib (PiqrayⓇ)

○ Fam-trastuzumab deruxtecan-nxki (EnhertuⓇ)

○ Tucatinib (Tukysa™)

○ Sacituzumab govitecan-hziy (Trodelvy™)

○ Pertuzumab 

○ Trastuzumab 

○ Hyaluronidase–zzxf (Phesgo™)

 

 

4. Lung (23)

○ Bevacizumab (AvastinⓇ)

○ Crizotinib (XalkoriⓇ)

○ Erlotinib (TarcevaⓇ)

○ Gefitinib (IressaⓇ)

○ Afatinib dimaleate (GilotrifⓇ)

○ Ceritinib (LDK378/Zykadia™)

○ Ramucirumab (CyramzaⓇ)

○ Nivolumab (OpdivoⓇ)

○ Pembrolizumab (KeytrudaⓇ)

○ Osimertinib (Tagrisso™)

○ Necitumumab (Portrazza™)

○ Alectinib (AlecensaⓇ)

○ Atezolizumab (TecentriqⓇ)

○ Brigatinib (Alunbrig™)

○ Trametinib (MekinistⓇ)

○ Dabrafenib (TafinlarⓇ)

○ Durvalumab (Imfinzi™)

○ Dacomitinib (VizimproⓇ)

○ Lorlatinib (LorbrenaⓇ)

○ Entrectinib (Rozlytrek™)

○ Capmatinib hydrochloride (Tabrecta™)

○ Ipilimumab (YervoyⓇ)

○ Selpercatinib (Retevmo™)

 

 

5. Skin (15)

○ Vismodegib (ErivedgeⓇ)

○ Sonidegib (OdomzoⓇ)

○ Ipilimumab (YervoyⓇ)

○ Vemurafenib (ZelborafⓇ)

○ Trametinib (MekinistⓇ)

○ Dabrafenib (TafinlarⓇ)

○ Pembrolizumab (KeytrudaⓇ)

○ Nivolumab (OpdivoⓇ)

○ Cobimetinib (Cotellic™)

○ Alitretinoin (PanretinⓇ)

○ Avelumab (BavencioⓇ)

○ Encorafenib (Braftovi™)

○ Binimetinib (MektoviⓇ)

○ Cemiplimab-rwlc (LibtayoⓇ)

○ Atezolizumab (TecentriqⓇ)

 

 

6. Kidney (13)

○ Bevacizumab (AvastinⓇ)

○ Sorafenib (NexavarⓇ)

○ Sunitinib (SutentⓇ)

○ Pazopanib (VotrientⓇ)

○ Temsirolimus (ToriselⓇ)

○ Everolimus (AfinitorⓇ)

○ Axitinib (InlytaⓇ)

○ Nivolumab (OpdivoⓇ)

○ Cabozantinib (Cabometyx™)

○ Lenvatinib mesylate (LenvimaⓇ)

○ Ipilimumab (YervoyⓇ)

○ Pembrolizumab (KeytrudaⓇ)

○ Avelumab (BavencioⓇ)

 

 

7. Liver (11)

○ Sorafenib (NexavarⓇ)

○ Regorafenib (StivargaⓇ)

○ Nivolumab (OpdivoⓇ)

○ Lenvatinib mesylate (LenvimaⓇ)

○ Pembrolizumab (KeytrudaⓇ)

○ Cabozantinib (Cabometyx™)

○ Ramucirumab (CyramzaⓇ)

○ Ipilimumab (YervoyⓇ)

○ Pemigatinib (Pemazyre™)

○ Atezolizumab (TecentriqⓇ)

○ Bevacizumab (AvastinⓇ)

 

 

8. Colorectal (10)

○ Cetuximab (ErbituxⓇ)

○ Panitumumab (VectibixⓇ)

○ Bevacizumab (AvastinⓇ)

○ Ziv-aflibercept (ZaltrapⓇ)

○ Regorafenib (StivargaⓇ)

○ Ramucirumab (CyramzaⓇ)

○ Nivolumab (OpdivoⓇ)

○ Ipilimumab (YervoyⓇ)

○ Encorafenib (Braftovi™)

○ Pembrolizumab (KeytrudaⓇ)

 

 

9. Prostate (8)

○ Cabazitaxel (JevtanaⓇ)

○ Enzalutamide (XtandiⓇ)

○ Abiraterone acetate (ZytigaⓇ)

○ Radium 223 dichloride (XofigoⓇ)

○ Apalutamide (Erleada™)

○ Darolutamide (NubeqaⓇ)

○ Rucaparib camsylate (Rubraca™)

○ Olaparib (Lynparza™)

 

 

10. Bladder (7)

○ Atezolizumab (TecentriqⓇ)

○ Nivolumab (OpdivoⓇ)

○ Durvalumab (Imfinzi™)

○ Avelumab (BavencioⓇ)

○ Pembrolizumab (KeytrudaⓇ)

○ Erdafitinib (Balversa™)

○ Enfortumab Vedotin-ejfv (Padcev™)

 

 

11. Thyroid (7)

○ Cabozantinib (CometriqⓇ)

○ Vandetanib (CaprelsaⓇ)

○ Sorafenib (NexavarⓇ)

○ Lenvatinib mesylate (LenvimaⓇ)

○ Trametinib (MekinistⓇ)

○ Dabrafenib (TafinlarⓇ)

○ Selpercatinib (Retevmo™)

 

 

12. Targeted therapy ＜ 5

○ gastric, cervical, ovarian, pancreatic, brain, head & neck, soft tissue sarcomam, MM, etc.

 

입력: 2021.12.19 22:43